Report topline results from Phase 2 SunStone trial in systemic lupus erythematosus
Not delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 5 Feb 2025
- Due
- 30 Jun 2026
- Checked
- 18 Sep 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“report topline results in the first half of 2026”
What we found
Evidence strength A What the grades mean
Zenas repeatedly pushed back the SunStone SLE topline readout from H1 2026 to Q4 2026, and results remained unreported as of its August 2026 update.
-
A Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial Guidance shifted to 'mid-2026' for SunStone topline results.
-
C Zenas BioPharma Reports First Quarter 2026 Financial Results Enrollment complete, but topline results still expected Q4 2026, not H1.
-
C Zenas BioPharma Reports Second Quarter 2026 Financial Results Confirms SunStone topline results still expected in Q4 2026, past deadline.
-
D Zenas BioPharma Reports Fourth Quarter and Full Year 2025 Financial Results Guidance revised to Q4 2026 for SunStone topline results.
Checked 18 Sep 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
How this entry was checked
- Commitment recordedRecorded from the company's filing.
- First checkAn AI model read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.
- Third check on a negative finding: agreesBecause a negative finding could harm a company if wrong, a stronger model re-read the evidence fully blind and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Zenas BioPharma, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-ZBIO-000211 · Corrections policy